Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
